High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
Rocket Lab stock gains as the company raises $1.944 billion via an ATM offering to fund Iridium deal. Here’s how you should play RKLB shares at current levels.
The rocket launch and satellite specialist just reached an important milestone in its historic acquisition.
The company completed its $1.94 billion at-the-market (ATM) stock offering, selling about 29.3 million shares.
The reason has less to do with rockets than with what’s inside the panels.
Rocket Lab continues to thrive in SpaceX's shadow.
President Donald Trump signed a memo Thursday directing federal agencies to dramatically ramp up commercial rocket activity, setting a target of at least 1,000 launches and re-entries annually by 2030, according to Reuters. Last year’s total sat at 178 launches...
Iridium (IRDM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
The company’s latest Space Force win points to a strategy shift investors may be underpricing.
A hiker outside cell range can still send a text for help, thanks to a satellite network most people never think about. Rocket Lab Corp. (RKLB) builds pieces of that network, and on Sunday, Aug. 16, it confirmed that eight satellites it built for MDA Space have reached orbit and begun operating, ...
Revenue surged 62% YoY to $234M as backlog hit $2.36B on major Space Force contracts.
A top market strategist just called out the biggest risk hiding inside Anthropic's upcoming IPO, and it has nothing to do with the quality of the company or its technology.
At first glance, stock indexes look muted today. But under the surface, many of the names that have become synonymous with the AI trade are making big strides today, likely helped by a late-Friday Bloomberg report that Anthropic's second-quarter revenue rose 14-fold.
Rocket Lab’s second-quarter results gave Bank of America another reason to stay bullish on the space company, even as one part of the business came in lighter than Wall Street expected. Bank of America reiterated its Buy rating and $115 price objective on Rocket Lab (RKLB) after earnings, analyst ...
HSR period lapses as Rocket Lab moves to replace a $3.6 billion bridge facility
The space stock's post-earnings pullback isn't too meaningful.
One crucial launch milestone could determine whether the bet pays
Rocket Lab (RKLB) delivered the type of quarter that should have put investors at ease. Revenue jumped62% year over year to a record $234 million, beating Wall Street expectations, while its space-systems business accounted for 81% of total sales. Instead, shares fell roughly 7% in extended ...
Futures for the Dow Jones Industrial Average and the other major stock indexes traded higher Tuesday, after it was reported the U.S. and Iran had reached "some sort of an arrangement" for a peace deal.
Shares of Rocket Lab traded down more than 4% premarket after the company indicated its forthcoming Neutron vehicle may not be ready to launch this year. The company said Monday it is planning to deliver the first Neutron rocket to a launch pad in the last quarter of 2026. In May, Rocket Lab said it was in position to debut the rocket this year.
Aerospace and defense company Rocket Lab (NASDAQ:RKLB) will be reporting results this Monday after the bell. Here’s what you need to know.
The space company posted $234 million in second-quarter revenue, up 62% year over year, but a per-share loss that missed analyst estimates
Rocket Lab Corp (RKLB) posts 62% revenue growth to $234 million, secures over $1 billion in new contracts, and advances Neutron development toward a Q4 2026 pad delivery.
Rocket Lab (NASDAQ:RKLB) reported record second-quarter 2026 revenue of $234 million, up 62% from a year earlier and 16.8% sequentially, as the company expanded its Space Systems business, added major government contracts and continued development of its Neutron medium-lift rocket. Founder and Chie
Rocket Lab Corp. (NASDAQ:RKLB) reports second-quarter earnings Monday after the close, with investors listening for an update on Neutron. Prediction market traders are overwhelmingly skeptical the company’s next-generation rocket flies this year. Traders on Kalshi assign just a 14% probability...
On this episode of Stock Movers: - RocketLab (RKLB) shares are higher this morning after rising Friday, following earnings from SpaceX last week. - Moderna (MRNA) shares are moving after last week's news that its mRNA flu shot won US approval in an FDA turnaround. - Intel (INTC) shares are moving after the company said it will be offering $15 billion in common stock, taking advantage of renewed interest in its business prospects during the artificial intelligence data center boom.
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.
